Boris Tchernychev
AeroLeads people directory · profile

Boris Tchernychev Email & Phone Number

Director at Inozyme Pharma at Inozyme Pharma
Location: Brookline, Massachusetts, United States 6 work roles 2 schools
1 work email found @inozyme.com LinkedIn matched
✓ Verified Jun 2026 4 data sources Profile completeness 100%

Contact Signals · 1 work email

Work email b****@inozyme.com
LinkedIn Profile matched
3 free lookups remaining · No credit card
Current company
Role
Director at Inozyme Pharma
Location
Brookline, Massachusetts, United States
Company size

Who is Boris Tchernychev? Overview

A concise factual answer block for searchers comparing this professional profile.

Quick answer

Boris Tchernychev is listed as Director at Inozyme Pharma at Inozyme Pharma, a company with 37 employees, based in Brookline, Massachusetts, United States. AeroLeads shows a work email signal at inozyme.com and a matched LinkedIn profile for Boris Tchernychev.

Boris Tchernychev previously worked as Director at Inozyme Pharma and Principal Investigator at Ironwood Pharmaceuticals. Boris Tchernychev holds Ph.D., Biology from Weizmann Institute Of Science.

Company email context

Email format at Inozyme Pharma

This section adds company-level context without repeating Boris Tchernychev's masked contact details.

{first}.{last}@inozyme.com
89% confidence

AeroLeads found 1 current-domain work email signal for Boris Tchernychev. Compare company email patterns before reaching out.

Profile bio

About Boris Tchernychev

Competent, detailed-oriented preclinical pharmacologists with multiple years of industrial experience. Knowledge of the drug discovery process with experience in project management. Strong background in animal models in different therapeutic areas encompassing common and rare diseases. Knowledge of multiple target classes including adhesion receptors, GPCRs, enzymes, and transcription factors. Experience in in vitro and ex vivo assays. Expertise in intravital microscopy and pharmacology of cell-penetrating peptides. Skillful in managing people and leading collaborations with CROs, academia, and industry partners. Extensively published and presented at professional meetings.

Listed skills include In Vivo Pharmacology, In Vivo Imaging, Cell Penetrating Peptides, Gpcr'S Pharmacology, and 25 others.

Current workplace

Boris Tchernychev's current company

Company context helps verify the profile and gives searchers a useful next step.

Inozyme Pharma
Inozyme Pharma
Director at Inozyme Pharma
boston, massachusetts, united states
Website
Employees
37
AeroLeads page
6 roles

Boris Tchernychev work experience

A career timeline built from the work history available for this profile.

Director

Current

451 D Street Suite 911, Boston, MA 02210

Oct 2020 - Present

Principal Investigator

301 Binney St., Cambridge MA 02142

  • Olinciguat/Sickle Cell Disease program:
  • Preclinical pharmacology LEAD for Olinciguat/Sickle Cell Disease (SCD) program.
  • Generated preclinical data resulting in approval of application for Orphan Drug Designation (ODD).
  • Ensured evaluation of sGC stimulator olinciguat in animal models of sickle cell crisis and nephropathy.
  • Led evaluation of olinciguat in in vitro and ex vivo assays.
  • Conducted preclinical validation of biomarkers for STRONG SCD Phase II study.
Jun 2012 - Dec 2019

Principal Scientist

Anchor Therapeutics

Cambridge, US

  • Member of Anchor Scientific Leadership Team (SLT).
  • Head of in vivo pharmacology.
  • Planned, initiated, and led evaluation of GPCRs-specific cell-penetrating peptides (pepducins) in animal models.
  • Designed and conducted PK and internal toxicology studies.
  • Provided project leadership to CXCR4/HSCs mobilization program to achieve program milestones.
  • Co-led collaboration with Johnson & Johnson on oncology target.
Jun 2008 - Mar 2012

Senior Scientist Ii

200 Cambridge Park Drive, Cambridge MA 02140

  • Head of intravital microscopy (IVM) facility.
  • Implemented IVM to evaluate lead candidates in animal models of athero-inflammation and thrombosis.
  • Developed critical ex vivo assays.
  • Led in vivo pharmacology studies resulting in out-licensing of PI3-kinase beta inhibitor program to GVK Biosciences LTD.
  • Supported in vivo evaluation of lead candidate for P-selectin program to advance program to Phase I.
  • Generated preclinical data to advance cPLA2 program to Development.
May 2005 - May 2008

Research Associate

Boston, Massachusetts, United States

  • Characterized PK/PD and Bio-Distribution of GPCRs-specific cell penetrating peptides (pepducins) to secure series A funding for Anchor Therapeutics.
  • Demonstrated the role of platelet-derived MMP-1 in propagation of arterial thrombi.
May 2003 - May 2005

Postdoctoral Research Fellow

Boston, Massachusetts, United States

  • Discovered and characterized P-selectin in mouse peritoneal macrophages.
  • Studied the role of P-, E-, L- selectin and PSGL-1 in monocyte trafficking.
  • Studied phenotype of PSGL-1 knockout mice.
Jul 1997 - May 2003
Team & coworkers

Colleagues at Inozyme Pharma

Other employees you can reach at inozyme.com. View company contacts for 37 employees →

2 education records

Boris Tchernychev education

FAQ

Frequently asked questions about Boris Tchernychev

Quick answers generated from the profile data available on this page.

What company does Boris Tchernychev work for?

Boris Tchernychev works for Inozyme Pharma.

What is Boris Tchernychev's role at Inozyme Pharma?

Boris Tchernychev is listed as Director at Inozyme Pharma at Inozyme Pharma.

What is Boris Tchernychev's email address?

AeroLeads has found 1 work email signal at @inozyme.com for Boris Tchernychev at Inozyme Pharma.

Where is Boris Tchernychev based?

Boris Tchernychev is based in Brookline, Massachusetts, United States while working with Inozyme Pharma.

What companies has Boris Tchernychev worked for?

Boris Tchernychev has worked for Inozyme Pharma, Ironwood Pharmaceuticals, Anchor Therapeutics, Wyeth Pharmaceuticals, and Tufts University.

Who are Boris Tchernychev's colleagues at Inozyme Pharma?

Boris Tchernychev's colleagues at Inozyme Pharma include David Thompson, Matthew Bandel, Christof Schulz, Katie Swanner, Pharmd, and Maggie Ondrey.

How can I contact Boris Tchernychev?

You can use AeroLeads to view verified contact signals for Boris Tchernychev at Inozyme Pharma, including work email, phone, and LinkedIn data when available.

What schools did Boris Tchernychev attend?

Boris Tchernychev holds Ph.D., Biology from Weizmann Institute Of Science.

What skills is Boris Tchernychev known for?

Boris Tchernychev is listed with skills including In Vivo Pharmacology, In Vivo Imaging, Cell Penetrating Peptides, Gpcr'S Pharmacology, Adhesion Receptors, Inflammation, Metabolic Diseases, and Stem Cells.

Find 750M verified contacts

Search by job title, company, industry, location, and seniority. Export verified B2B contact data when you need it.